Institut de Recherche en Cancérologie de Montpellier
Sommaire
Projet scientifique
Publications
Equipe

Principales publications

Docquier A, Harmand PO, Fritsch S, Chanrion M, Darbon JM, Cavaillès V. The Transcriptional Coregulator RIP140 Represses E2F1 Activity and Discriminates Breast Cancer Subtypes. Clin Cancer Res. 2010 May 18. [Epub ahead of print]PMID: 20410059

Savatier J, Jalaguier S, Ferguson ML, Cavaillès V, Royer CA. Estrogen Receptor Interactions and Dynamics Monitored in Live Cells by Fluorescence Cross-Correlation Spectroscopy. Biochemistry. 2010 Jan 7. [Epub ahead of print]

Teyssier C, Le Romancer M, Sentis S, Jalaguier S, Corbo L, Cavaillès V. Protein arginine methylation in estrogen signaling and estrogen-related cancers. Trends Endocrinol Metab.. [Epub ahead of print]

Badia E, Escande A, Balaguer P, Metivier R, Cavailles V. New stably transfected bioluminescent cells expressing FLAG epitope-tagged estrogen receptors to study their chromatin recruitment. BMC Biotechnol 2009; 9: 77

le Maire A, Grimaldi M, Roecklin D, Dagnino S, Vivat-Hannah V, Balaguer P, Bourguet W. Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Rep 2009; 10: 367-373

Duong V, Bret C, Altucci L, Mai A, Duraffourd C, Loubersac J, Harmand PO, Bonnet S, Valente S, Maudelonde T, Cavailles V, Boulle N. Specific Activity of Class II Histone Deacetylases in Human Breast Cancer Cells. Mol Cancer Res. 2008 Dec;6(12):1908-19.

Molina-Molina JM, Escande A, Pillon A, Gomez E, Pakdel F, Cavailles V, Olea N, Ait-Aissa S,Balaguer P. Profiling of benzophenone derivatives using fish and human estrogen receptor-specific in vitro bioassays. Toxicol Appl Pharmacol 2008; 232: 384-395.

Duong V, Augereau P, Badia E, Jalaguier S, Cavailles V. Regulation of hormone signaling by nuclear receptor interacting proteins. Adv Exp Med Biol 2008; 617: 121-127.

Duong, V., Boulle, N., Daujat, S., Chauvet, J., Bonnet, S., Neel, H., and Cavailles, V. Differential Regulation of Estrogen Receptor {alpha} Turnover and Transactivation by Mdm2 and Stress-Inducing Agents. Cancer Res, 67: 5513-5521, 2007.

Augereau, P., Badia, E., Fuentes, M., Rabenoelina, F., Corniou, M., Derocq, D., Balaguer, P., and Cavailles, V. Transcriptional regulation of the human NRIP1/RIP140 gene by estrogen is modulated by dioxin signalling. Mol Pharmacol, 69: 1338-1346, 2006.

Gobinet, J., Carascossa, S., Cavailles, V., Vignon, F., Nicolas, J. C., and Jalaguier, S. SHP represses transcriptional activity via recruitment of histone deacetylases. Biochemistry, 44: 6312-6320, 2005.

Carascossa, S., Gobinet, J., Georget, V., Lucas, A., Badia, E., Castet, A., White, R., Nicolas, J. C., Cavailles, V., and Jalaguier, S. Receptor-interacting protein 140 is a repressor of the androgen receptor activity. Mol Endocrinol, 20: 1506-1518, 2006.

Castet, A., Herledan, A., Bonnet, S., Jalaguier, S., Vanacker, J. M., and Cavailles, V. Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol Endocrinol, 20: 1035-1047, 2006.

Dahlman-Wright, K., Cavailles, V., Fuqua, S. A., Jordan, V. C., Katzenellenbogen, J. A., Korach, K. S., Maggi, A., Muramatsu, M., Parker, M. G., and Gustafsson, J. A. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev, 58: 773-781, 2006.

Lemaire, G., Mnif, W., Pascussi, J. M., Pillon, A., Rabenoelina, F., Fenet, H., Gomez, E., Casellas, C., Nicolas, J. C., Cavailles, V., Duchesne, M. J., and Balaguer, P. Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. Toxicol Sci, 91: 501-509, 2006.

Escande, A., Pillon, A., Servant, N., Cravedi, J. P., Larrea, F., Muhn, P., Nicolas, J. C., Cavailles, V., and Balaguer, P. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol, 71: 1459-1469, 2006.

Seimandi, M., Lemaire, G., Pillon, A., Perrin, A., Carlavan, I., Voegel, J. J., Vignon, F., Nicolas, J. C., and Balaguer, P. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands. Anal Biochem, 344: 8-15, 2005.

Pillon, A., Boussioux, A. M., Escande, A., Ait-Aissa, S., Gomez, E., Fenet, H., Ruff, M., Moras, D., Vignon, F., Duchesne, M. J., Casellas, C., Nicolas, J. C., and Balaguer, P. Binding of estrogenic compounds to recombinant estrogen receptor-alpha: application to environmental analysis. Environ Health Perspect, 113: 278-284, 2005.

 

Institut de Recherche en Cancérologie de Montpellier - 2007 - tous droits réservés - Conception : ID Alizés